A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 121
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Ad5
Long Form : adenovirus 5
No. Year Title Co-occurring Abbreviation
2020 A Bivalent Human Adenovirus Type 5 Vaccine Expressing the Rabies Virus Glycoprotein and Canine Distemper Virus Hemagglutinin Protein Confers Protective Immunity in Mice and Foxes. CDV, RABV
2020 A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer. DL, TAA, vp
2020 Algorithm-Based Liquid Formulation Development Including a DoE Concept Predicts Long-Term Viral Vector Stability. DoE
2020 Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5. CAR
2019 Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. BD, HFD, NAFLD
2019 Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation. ---
2019 Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells. Ad6
2019 Patchy Amphiphilic Dendrimers Bind Adenovirus and Control Its Host Interactions and in Vivo Distribution. ---
2018 A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy. ADP, MHC-I, NK, TAP
10  2018 Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. ---
11  2018 Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. ZIKV
12  2018 Role of kinesins in directed adenovirus transport and cytoplasmic exploration. Pb
13  2018 Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX. CAR
14  2017 Crosstalk Between Transforming Growth Factor Beta-2 and Toll-Like Receptor 4 in the Trabecular Meshwork. cFN, ECM, IOP, TLR4, TM
15  2017 Gene therapy for human ovarian cancer cells using efficient expression of Fas gene combined with gammadeltaT cells. FAS, hTERT, TSTA
16  2017 Phosphatidylserine Exposure Controls Viral Innate Immune Responses by Microglia. PLSCR1, PtdSer
17  2017 Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens. HCV, MVA
18  2016 Approaches to preventative and therapeutic HIV vaccines. ---
19  2016 Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. AAV2, FX, HSPGs
20  2016 Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response. PML
21  2016 The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Can Mimic E1A Effects on E2F. Rb
22  2015 A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys. CSP, rAds
23  2015 Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection. MOIs, RISCs, VA RNAs
24  2015 Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies. EGFR, EOC, FGFR1, hFX
25  2015 Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor. ---
26  2014 Ad5/48 hexon oncolytic virus expressing sTGFbetaRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases. PCa, sTGbetaRIIFc
27  2014 Capsid-Damaging Effects of UV Irradiation as Measured by Quantitative PCR Coupled with Ethidium Monoazide Treatment. LP, MP, PV1
28  2014 Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. FMD, FMDV, IFN, IFNs
29  2014 Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. Ad5-Gag, DCs, pGag, SP-D
30  2014 [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors]. Ang, IGF, MND, VEGF
31  2013 A single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock. Ad40, rAd40
32  2013 An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine. Ad5-A24, FMDV, LT
33  2013 Nonreplicating vectors in HIV vaccines. HVTN
34  2013 The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity. ---
35  2013 Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus. FMDV, VEE, VRP-GFP
36  2012 The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment. hTERT
37  2011 A cluster of basic amino acids in the factor X serine protease mediates surface attachment of adenovirus/FX complexes. FX, HSPGs, SP
38  2011 Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults. AMA1, CSP
39  2011 An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice. CMI, TAA
40  2011 Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models. Ad, Ad5-CL, CAR
41  2011 Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. AIDS, HIV, RhCMV, SIV
42  2010 Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells. Ad5-AL, Ad5-CL, CAR
43  2010 Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. dpi, FMDV, IFN, ISG
44  2010 The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2. ImVacS
45  2009 Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. ---
46  2009 Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters. ---
47  2009 Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice. GP, LCMV
48  2009 Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. ---
49  2008 Enhanced transduction and improved photoreceptor survival of retinal degeneration by the combinatorial use of rAAV2 with a lower dose of adenovirus. rAAV
50  2008 Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1. Ad5dn, LPS, MDP, PC1
51  2008 [HIV/AIDS vaccines: heading for new vaccine approaches?]. ---
52  2008 [The effects of adenovirus 5 latent infection on pulmonary inflammation caused by biomass fumes in guinea pigs]. ANOVA, BALF, CAM-1, IL
53  2007 A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis. MVA
54  2007 CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo. HIV-1, PBMCs
55  2007 Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus. CPE, PAMs, PRRSV, swIFN-beta
56  2007 Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines. ---
57  2007 Toxicity of fiber- and penton base-modified adenovirus type 5 vectors on lung development in newborn rats. ADDs, PD, TUNEL
58  2006 Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. iNOS, LV
59  2006 Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis. i.n, IM, JEV, rAds
60  2006 Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. ---
61  2006 Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. PML
62  2006 Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. HI, SIV
63  2006 Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. ---
64  2006 [Expression of B7 molecules and TLR-9 on corneal epithelial cells infected with adenovirus: clinico-pathological implications in viral keratoconjunctivitis]. CEC, SE
65  2005 Adiposity induced by adenovirus 5 inoculation. MRS
66  2005 Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. ---
67  2005 Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. AAV, GFP, p.i
68  2005 Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice. SARS-CoV
69  2003 Developing novel oncolytic adenoviruses through bioselection. ---
70  2003 Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes. PAC, YAP
71  2002 [Delivery of secreted placental alkaline phosphatase (SEAP) gene in vitro and in vivo as a component of recombinant avian adenovirus (CELO)]. SEAP
72  2001 Effects of adenovirus-mediated liver-selective overexpression of protein tyrosine phosphatase-1b on insulin sensitivity in vivo. EGP, PTP-1B, W/T
73  2001 Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer. VCAM-1
74  1999 Dynamic redistribution of nuclear matrix proteins by adenovirus infection. ---
75  1999 The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1). ---
76  1998 Adenovirus death protein, a transmembrane protein encoded in the E3 region, is palmitoylated at the cytoplasmic tail. Ad2, ADP
77  1998 An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. IR, TNF-alpha, TNFi
78  1998 In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. ---
79  1998 Ovine adenovirus (OAV287) lacks a virus-associated RNA gene. VA
80  1997 The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300. ---
81  1996 A hydrophobic region within the adenovirus E1B 19 kDa protein is necessary for the transient inhibition of NF-kappaB activated by different stimuli. ---
82  1996 A model of latent adenovirus 5 infection in the guinea pig (Cavia porcellus). ---
83  1996 Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. HER, rAdV
84  1996 Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. Ad, BUGT1
85  1996 Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. ---
86  1995 HER-2/neu-targeting gene therapy--a review. ---
87  1995 Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus. Ad-gp50, Env, FIV, PRV
88  1995 [Expression of a gene encoding the porcine rotavirus VP7 capsid using a nondefective recombinant adenoviral genome]. ---
89  1994 Endotoxins and prednisolone alter replication of type 5 adenovirus and its temperature sensitive mutants. RD, TNF-alpha, WT
90  1994 In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. CF, CFTR
91  1994 Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. hdm-2
92  1993 Expression of the gene encoding secreted placental alkaline phosphatase (SEAP) by a nondefective adenovirus vector. SEAP
93  1993 Inhibition of cell-proliferation by an adenovirus vector expressing the human wild type-p53 protein. WT
94  1993 Multiple pathways for gene activation in rodent cells by the smaller adenovirus 5 E1A protein and their relevance to growth and transformation. BRK
95  1993 Selective effects on adenovirus late gene expression of deleting the E1b 55K protein. ---
96  1993 Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. E1A and E1B
97  1991 Adenovirus type 5 E3 gene products interfere with the expression of the cytolytic T cell immunodominant E1a antigen. WT
98  1991 Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice. ---
99  1990 A 14,500 MW protein is coded by region E3 of group C human adenoviruses. ---
100  1990 Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. ---